The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Epithelial-mesenchymal transition in patients with HER2+ metastatic breast cancer.
A. Giordano
No relevant relationships to disclose
M. Mego
No relevant relationships to disclose
B. Lee
No relevant relationships to disclose
S. Anfossi
No relevant relationships to disclose
C. A. Parker
No relevant relationships to disclose
R. H. Alvarez
No relevant relationships to disclose
N. T. Ueno
No relevant relationships to disclose
V. Valero
No relevant relationships to disclose
M. Cristofanilli
No relevant relationships to disclose
J. M. Reuben
No relevant relationships to disclose